Two pharmaceutical enterprises promised to decrease some medications under the proposal of the Vietnam Drug Administration (VDA).
|Cardiovascular drug Vasterel will be decreased 10 percent as Les Laboratoires Servier promises to reduce its price|
In response to VDA’s appeal to foreign pharmaceutical enterprises in Vietnam for reducing prices of drugs, Ebewe Pharma GmbH Nfg. KG of Austria and Les Laboratoires Servier of France sent a notification to VDA to say they will reduce prices of specific drugs for treatment of cancer, heart diseases, diabetes and antibiotics.
Austria’s pharmaceutical companies said it will decrease 16 medications over 31 for treatment cancer diseases. Its products will have an average decrase from 5 percent to 12 percent.
Meanwhile France said it decreased by 7 percent for drugs for treatment diabetes (Diamicron 80mg) and 10 percent for cardiovascular disease medicines (Vastaren).
In addition, GlaxoSmithKline (GSK) is considering reducing prices of some drugs with huge turnover and quantity, including antibiotic for adults and kids.
Especially, these companies pledged to keep stable supply of specific drugs in hospital pharmacies.